Works matching IS 00099236 AND DT 2024 AND VI 116 AND IP 6
Results: 34
HIGHLIGHTED ARTICLES.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1369, doi. 10.1002/cpt.3476
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1371, doi. 10.1002/cpt.3475
- Publication type:
- Article
Therapeutic Orphan No More: Role for Clinical Pharmacology and Translational Science in Developing Therapeutics for Rare and Neglected Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1363, doi. 10.1002/cpt.3474
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1361, doi. 10.1002/cpt.3473
- Publication type:
- Article
First‐in‐Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1580, doi. 10.1002/cpt.3470
- By:
- Publication type:
- Article
Model‐Informed Approach to Recommend Burosumab Dosing Regimens for Pediatric and Adult Patients With the Ultrarare Disease Tumor‐Induced Osteomalacia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1606, doi. 10.1002/cpt.3468
- By:
- Publication type:
- Article
Longitudinal Analysis of Natural History Progression of Rare and Ultra‐Rare Cerebellar Ataxias Using Item Response Theory.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1593, doi. 10.1002/cpt.3466
- By:
- Publication type:
- Article
Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1442, doi. 10.1002/cpt.3451
- By:
- Publication type:
- Article
Infrequent Resolution of Vaso‐Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa‐Cel Trial Population: A Cohort Study of Medicaid Enrollees.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1572, doi. 10.1002/cpt.3449
- By:
- Publication type:
- Article
What Is Rare and What Is Orphan? A Guide to the Regulatory Terminology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1395, doi. 10.1002/cpt.3446
- By:
- Publication type:
- Article
External Controls to Study Treatment Effects in Rare Diseases: Challenges and Future Directions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1521, doi. 10.1002/cpt.3443
- By:
- Publication type:
- Article
Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure–Response Models, and Real‐World Patient Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1635, doi. 10.1002/cpt.3441
- By:
- Publication type:
- Article
Rare Diseases Linked to Mutations in Vitamin Transporters Expressed in the Human Blood–Brain Barrier.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1513, doi. 10.1002/cpt.3433
- By:
- Publication type:
- Article
Diagnosis and Management of Parathyroid Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1496, doi. 10.1002/cpt.3432
- By:
- Publication type:
- Article
First‐in‐Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS‐986308: A Renal Outer Medullary Potassium Channel Inhibitor.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1627, doi. 10.1002/cpt.3430
- By:
- Publication type:
- Article
The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1387, doi. 10.1002/cpt.3428
- By:
- Publication type:
- Article
The Promise of Health for All: A Collaborative Model to Close Treatment Gaps for Neglected Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1385, doi. 10.1002/cpt.3427
- By:
- Publication type:
- Article
Model‐Informed Approaches to Optimizing Therapeutics in the African Patient Populations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1391, doi. 10.1002/cpt.3425
- By:
- Publication type:
- Article
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1433, doi. 10.1002/cpt.3422
- By:
- Publication type:
- Article
Progress in Pharmacometrics Implementation and Regulatory Integration in Africa: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1525, doi. 10.1002/cpt.3415
- By:
- Publication type:
- Article
Ongoing Pharmacological Developments in SLC6A1 Research & Treatment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1381, doi. 10.1002/cpt.3413
- By:
- Publication type:
- Article
Developmental Expression of Drug Transporters and Conjugating Enzymes Involved in Enterohepatic Recycling: Implication for Pediatric Drug Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1615, doi. 10.1002/cpt.3409
- By:
- Publication type:
- Article
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1412, doi. 10.1002/cpt.3407
- By:
- Publication type:
- Article
Assessing Post‐Marketing Requirements for Orphan Drugs: A Cross‐Sectional Analysis of FDA and EMA Oversight.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1560, doi. 10.1002/cpt.3397
- By:
- Publication type:
- Article
From Challenge to Opportunity: How Shwachman–Diamond Syndrome Became a Promising Target for Therapy Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1377, doi. 10.1002/cpt.3393
- By:
- Publication type:
- Article
Impact of Priority Review Voucher Eligibility on Research and Development of Medical Countermeasures.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1554, doi. 10.1002/cpt.3388
- By:
- Publication type:
- Article
Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra‐Rare Disease Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1485, doi. 10.1002/cpt.3382
- By:
- Publication type:
- Article
New Horizons of Model Informed Drug Development in Rare Diseases Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1398, doi. 10.1002/cpt.3366
- By:
- Publication type:
- Article
Systemic Treatment of Body‐Wide Duchenne Muscular Dystrophy Symptoms.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1472, doi. 10.1002/cpt.3363
- By:
- Publication type:
- Article
Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1544, doi. 10.1002/cpt.3360
- By:
- Publication type:
- Article
Attaining Equity of Access to Research: Perspective on Research in Pregnancy and Breastfeeding Following Dolores Shockley Lecture at ASCPT2024.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1506, doi. 10.1002/cpt.3344
- By:
- Publication type:
- Article
Advances in Clinical Therapies for Huntington's Disease and the Promise of Multi‐Targeted/Functional Drugs Based on Clinicaltrials.gov.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1452, doi. 10.1002/cpt.3341
- By:
- Publication type:
- Article
Medications and Acute Hemolysis in G6PD‐Deficient Patients – A Real‐World Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1537, doi. 10.1002/cpt.3333
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 6, p. 1353, doi. 10.1002/cpt.2949
- Publication type:
- Article